p53 Oncoprotein Expression and Proliferation Index in Keratoacanthoma and Squamous Cell Carcinoma

Archives of Dermatology

Volumn 130, Issue 2, 1994, Pages 181-186

  Kerschmann, Russell L ^a   Mccalmont, Timothy H ^a   Leboit, Philip E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KERATOACANTHOMA; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SKIN NEOPLASMS;

EID: 0028178989     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1994.01690020047007     Document Type: Article

References (37)

1. 1. Hueston JT. Keratoacanthoma, keratoses and Bowens's disease. In: Emmett AJJ, O'Rourke MGE, eds. Malignant Skin Tumors. Edinburgh: Churchill-Livingstone Publishers; 1991: 163-172.
2. 2. Weinberg RA. Tumor suppressor genes. Science. 1992; 254: 1139-1146.
3. 3. Hollingsworth RE, Lee WH. Tumour suppressor genes: new prospects for cancer research. J Natl Cancer Inst. 1991; 83: 91-96.
4. 4. Harris AL. Mutant p53: the commonest genetic abnormality in human cancer? J Pathol. 1990; 162: 5-6.
5. 5. Oren M. p53: the ultimate tumor suppressor gene? FASEB J. 1992; 6: 3169-3175.
6. 6. Finlay CA, Hinds PW, Levin AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989; 57: 1083-1093.
7. 7. Lane DP. p53, Guardian of the genome. Nature. 1992; 358: 15-16.
8. 8. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356: 215-221.
9. 9. Verhuijen R, Kuipers HJH, Schlingemann RO, et al. Ki-67 detects a nuclear matrix-associated proliferation-related antigen, I: intracellular localization during metaphase. J Cell Sci. 1989; 92: 123-130.
10. 10. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffinembedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991; 39: 471-478.
11. 11. Tacha DE, McKinney L. Casein reduces nonspecific background staining in immunolabeling techniques. J Histotechnol. 1992; 15: 127-132.
12. 12. Rook A, Whimster IW. Le keratoacanthome. Arch Belg Dermatol Syphilol. 1950; 6: 137-146.
13. 13. King DF, Barr RJ. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma and squamous cell carcinoma. J Cutan Pathol. 1980; 7: 140-148.
14. 14. Jordan RCK, Kahn HJ, From L, Jambrosic J. Immunohistochemical demonstration of actinically damaged elastic fibers in keratoacanthomas: an aid to diagnosis. J Cutan Pathol. 1991; 18: 81-86.
15. 15. Ackerman AB. The histology of keratoacanthoma. In: Andrade R, Gumpert S, Popkin G, Rees T, eds. Cancer of the Skin. Philadelphia, Pa: WB Saunders Co; 1974.
16. 16. Calonje E, Jones EW. Intravascular spread of keratoacanthoma. Am J Dermatopathol. 1992; 14: 414-417.
17. 17. Randall MB. Geisinger KR, Kute TE, Buss DH, Prichard RW. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma. Am J Clin Pathol. 1990; 93: 259-262.
18. 18. Stephenson TJ, Nichols CE, Cotton DWK. Can keratoacanthoma and squamous cell carcinoma be distinguished by flow cytometry and immunohistochemistry? J Pathol. 1987; 151: 238A. Abstract.
19. 19. Frentz G, Moller U, Larsen JK. DNA flow cytometry of human epidermal tumours. Virchows Arch Cell Pathol. 1985; 48: 175-183.
20. 20. Smoller BR, Kwan TH, Said JW, Banks-Schlegel S. Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins. J Am Acad Dermatol. 1986; 14: 226-234.
21. 21. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors. Am J Pathol. 1992; 140: 145-153.
22. 22. Shea CR, McNutt NS, Volkenandt M, Lugo J, Prioleau PG, Albino AP. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol. 1992; 141: 25-29.
23. 23. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol. 1992; 19: 302-308.
24. 24. Banks L, Matlashewski G, Crawford L. Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem. 1986; 159: 529-534.
25. 25. Stephenson TJ, Royds J, Silcocks PB, Bleehen SS. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma. Br J Dermatol. 1992; 127: 566-570.
26. 26. Slater S, McGrath JA, Hobbs C, Eady RAJ, McKee PH. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa. Histopathology. 1992; 20: 237-241.
27. 27. Piscioli F, Zumiani G, Boi S, Cristofolini M. A gigantic, metastasizing keratoacanthoma: report of a case and discussion on classification. Am J Dermatopathol. 1984; 6: 123-129.
28. 28. Heyderman E, Dagg B. p53 Immunostaining in benign breast disease. Lancet. 1991; 338: 1532.
29. 29. LeBoit PE, Sexton M. Microcystic adnexal carcinoma: differential diagnosis and differentiation of an underrecognized adnexal neoplasm. J Am Acad Dermatol. 1993; 29: 609-618.
30. 30. Tadini G, Cerri A, Crosti L, Cattoretti G, Berti E. p53 and oncogene expression in psoriasis. Acta Derm Venereol (Stockh). 1989; 146(suppl): 33-35.
31. 31. Herzberg AJ. Significance of DNA ploidy in cutaneous lesions. Arch Dermatol. 1991; 128: 663-672.
32. 32. Kerr JFR, Searle J. A suggested explanation for the paradoxical slow growth rate of basal cell carcinomas that contain numerous mitotic figures. J Pathol. 1971; 107: 41-44.
33. 33. Davidoff AM, Herndon JH II, Glover NS, et al. Relationship between p53 overexpression and established prognostic factors in breast cancer. Surgery. 1991; 110: 254-259.
34. 34. Gassenmeister A, Pfister H, Hornstein OP. Human papillomavirus 25-related DNA in solitary keratoacanthoma. Arch Dermatol Res. 1986; 279: 273-276.
35. 35. Scheffner M, Werness BA, Huibregeste JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63: 1129.
36. 36. Brash DE, Rudolf JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991; 88: 10124-10128.
37. 37. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M. Carcinogenspecific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 1992; 52: 6400-6403.